Company news
Liaoning Chengda Biotechnology Co. Ltd. news in 2025
Liaoning Chengda Biotechnology Co. Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Adjusting the Internal Investment Structure of Partial Investment Projects Financed by Raised Funds
December 18, 2025
Announcement on the Postponement of Certain Fundraising Projects, Adjustment of Internal Investment Structure, and Capital Injection to Wholly-owned Subsidiaries for the Implementation of New Fundraising Subprojects
December 5, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 20, 2025
Announcement on Using Partial Idle Raised Funds for Cash Management
October 29, 2025
Announcement on Voluntary Disclosure of Signing Strategic Cooperation Agreement
October 21, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 1, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
August 28, 2025
Announcement on the 1st Repurchase of Repurchased Shares through Call Auction
August 25, 2025
Announcement on Change of Directors of the Company
August 12, 2025
Announcement on Changing the Secretary of the Board of Directors
July 29, 2025
Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning Shares Repurchase
June 24, 2025
Announcement on Resolution of the 19th Meeting of the 5th Board of Directors
June 19, 2025
Indicative Announcement on the Chairman's Proposal to Repurchase the Company's Shares
June 17, 2025
Announcement on Implementation of Dividend Distribution of 2024
June 3, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 14, 2025
Report for Q1 2025
April 29, 2025
Announcement on Convening Performance Briefing for 2024 and Q1 2025
April 24, 2025
Notice on Convening the 2024 Annual General Meeting
April 23, 2025
Announcement on Listing and Circulation of Some Restricted Stocks in Initial Public Offering
April 18, 2025
Announcement on Completion of Share Delivery for Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.
April 11, 2025
Announcement on Result of Tender Offer and Stock Resumption for Shaoguan Gaoteng Enterprise Management Co., Ltd.
April 7, 2025
Announcement on Expiration of Tender Offer and Stock Suspension of Shaoguan Gaoteng Enterprise Management Co., Ltd.
April 3, 2025
Third Indicative Announcement on Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.
March 27, 2025
Second Indicative Announcement on Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.
March 20, 2025
Announcement on Voluntary Disclosure of the Entry of the Human Papillomavirus15-valent Vaccine (Escherichia Coli) into Phase II Clinical Trials
March 19, 2025
First Indicative Announcement on Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.
March 13, 2025
Indicative Announcement on Completion of Change of Actual Controller
March 2, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 25, 2025